DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sprx-3 is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in SPRX-3 is phendimetrazine tartrate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
A generic version of SPRX-3 was approved as phendimetrazine tartrate by VIRTUS PHARMS on December 31st, 1969.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Solvay||SPRX-3||phendimetrazine tartrate||CAPSULE;ORAL||085897-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|